An estimated 14.5 million cancer survivors currently live in the United States, with this number expected to increase to 19 million by 2024. 1, 2 These figures highlight the public health magnitude of cancer survivorship and the importance of understanding and addressing the needs of cancer survivors. A robust body of research is essential for developing the evidence base needed to generate care standards and clinical practice guidelines that can improve the quality of cancer survivorship and informing the design of cancer therapy regimens that reduce the occurrence and severity of treatment-related adverse effects while maintaining equivalent cure rates.

The number of published survivorship studies has increased steadily since 1986 when the National Coalition for Cancer Survivorship was formed, 3 with an observable increase around 1996 when the National Cancer Institute Office of Cancer Survivorship was created. 4 Although the volume of cancer survivorship research has grown considerably, more research (especially that focused on optimal survivorship care delivery) is greatly needed. 5 In 2011, ASCO established the Cancer Survivorship Committee to provide leadership and oversight for its cancer survivorship activities. In 2013, the committee produced the ASCO statement Achieving